Sanjivani Paranteral Ltd (SANJIVIN) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Sanjivani Paranteral Ltd on NSE and BSE, with an AI summary of each filing.
Sanjivani Paranteral Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve 1. To approve the Un-Audited ....
Intimation · 05 Nov 2026, 5:30 am
Sanjivani Paranteral Schedules Board Meeting for Q2 FY27 Financial Results Sanjivani Paranteral Limited has notified BSE that its Board of Directors will meet on 5th Nov'26 at its registered office. The board will consider and approve the un-audited financial results along with the Limited Review Report for the second quarter ended 30th Sep'26, pursuant to Regulation 29 and Regulation 33 of SEBI LODR Regulations, 2015. Approved financial results will be disseminated following the conclusion of the meeting.
Disclosure under regulation 30
Others (Uncategorized) · 23 Sept 2026, 9:18 pm
Sanjivani Paranteral Clarifies Utilization Plan for Convertible Warrant Issue Proceeds Sanjivani Paranteral Limited clarified the object of issuing up to 5,00,000 convertible warrants following queries from BSE. Out of the proposed warrant issue proceeds, approximately ₹5.80 Crore will be deployed toward capital expenditure and subsidiary working capital needs. Specifically, ₹1.57 Crore is allocated for machinery, HVAC systems, and utilities, while the company will contribute ₹9.38 Crore toward its subsidiary's total working capital requirement of ₹15.64 Crore. The balance funding requirement will be financed through internal accruals to support future operational expansion.
Scrutinizer Report for the Annual General Meeting held on 16th September, 2026
Annual General Meeting · 16 Sept 2026, 10:00 pm
Proceeding and Outcome of 32nd Annual General Meeting of the Company
Annual General Meeting · 16 Sept 2026, 9:54 pm
Record Date for AGM
Others · 25 Aug 2026, 3:54 am
Notice of AGM for FY 2025-26
Annual General Meeting · 25 Aug 2026, 3:48 am
Annual Report of Financial Year 2025-26
Others (Uncategorized) · 25 Aug 2026, 3:44 am
Quarter ended 30th June, 2026
Press Release · 14 Aug 2026, 9:50 pm
Sanjivani Parenteral Q1FY27: Strong EBITDA Growth and Margin Expansion Sanjivani Paranteral reported strong Q1FY27 results, with Total Income rising 33.81% YoY to ₹239.90 Mn. EBITDA grew 61.04% YoY to ₹43.21 Mn, leading to an EBITDA margin expansion of 305 Bps to 18.01%. PAT increased 43.94% YoY to ₹24.91 Mn, with PAT margin at 10.38%. Growth was driven by exports, which contributed 90.5% of revenue and grew 33.49% YoY. The Injectables segment, accounting for 56.59% of revenue, posted 22.54% YoY growth. EPS stood at ₹2.03, up 43.97% YoY.
Quarter ended 30th June, 2026
Investor Presentation · 14 Aug 2026, 9:48 pm
Sanjivani Paranteral Q1 FY27: Strong YoY Growth Driven by New IV-Fluid Business Sanjivani Paranteral reported robust Q1 FY27 consolidated results with revenue growing 33.8% YoY to ₹238.4 Mn and PAT up 43.9% YoY to ₹24.9 Mn. This growth was driven by the new IV-fluid subsidiary contributing ₹43.8 Mn in revenue. EBITDA surged 61.0% YoY to ₹43.2 Mn, with margins expanding to 18.0% from 15.0%. The company expects export recovery to continue after Q4 disruptions. Management guides for ₹1,450 Mn FY27 revenue, combining base business (₹800-850 Mn) and the new IV plant (₹600-650 Mn).
Outcome of Board Meeting held on Friday, 14th August, 2026
Outcome · 14 Aug 2026, 7:45 pm
Sanjivani Paranteral Reports Strong Q1 FY27 Results Sanjivani Paranteral reported robust consolidated results for Q1 ending 30th Jun'26, with revenue from operations growing 33.3% YoY to ₹2383.92 lacs. Net Profit (PAT) increased 43.9% YoY to ₹249.11 lacs from ₹173.06 lacs. Sequentially, revenue surged 80.4% QoQ while PAT jumped 354.2% QoQ from ₹54.85 lacs. The Board also announced its 32nd AGM will be held on 16th Sep'26 via VC/OAVM. The register of members will be closed from 10th Sep'26 to 16th Sep'26 for the AGM.
Finacials Results for the Quarter ended 30th June, 2026
Financial Result · 14 Aug 2026, 7:41 pm
Sanjivani Paranteral Ltd - Financial Result for the Quarter ended 30th Jun'26 (Consolidated, INR Lacs) ■ Revenue: 2,384 (+33.2% YoY | +80.4% QoQ) ■ EBITDA: 417 (+57.5% YoY | +164.4% QoQ) ■ EBITDA Margin (%): 17.5 (+270 bps YoY | +556 bps QoQ) ■ PAT: 241 (+39.4% YoY | +242.7% QoQ) ■ EPS (INR): 2.03 (+44.0% YoY | +314.3% QoQ)
Sanjivani Paranteral Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve 1. To consider and approve ....
Intimation · 14 Aug 2026, 5:30 am
As per Attachment
Others (Uncategorized) · 24 Jul 2026, 1:45 am
Sanjivani Paranteral to Raise INR 7.37 Crore via Preferential Warrants to Promoter Sanjivani Paranteral’s board on 23rd Jul'26 approved a preferential issue of up to 500,000 convertible warrants to promoter Mr. Ashwani Khemka. The issue price is set at INR 147.39 per warrant, aggregating up to INR 7.37 crore. Each warrant is convertible into one equity share within 18 months. Post-allotment, the promoter's shareholding will increase from 29.88% to 32.62%. The board also approved a related-party transaction with its subsidiary, SPL Infusion Private Limited. Shareholder approval will be sought via postal ballot.
As per attachement
Outcome · 24 Jul 2026, 1:42 am
Sanjivani Paranteral Board Approves INR 7.37 Cr Warrant Issue to Promoter The Board of Sanjivani Paranteral on 23rd Jul'26 approved a preferential issue of up to 500,000 convertible warrants to promoter Mr. Ashwani Khemka. Priced at INR 147.39 per warrant, the issue aggregates up to INR 7.37 crore. Warrants are convertible into equity shares (FV INR 10) within 18 months. Post-conversion, the promoter's shareholding would increase from 29.88% to 32.62%. The transaction is subject to shareholder approval. This move signals promoter confidence and provides growth capital for the company.
Sanjivani Paranteral Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/07/2026 ,inter alia, to consider and approve 1. To consider and discuss ....
Intimation · 23 Jul 2026, 5:30 am
Sanjivani Paranteral Board to Consider Fundraising Proposal Sanjivani Paranteral Limited has scheduled a Board Meeting on 23rd Jul'26 to consider a proposal for raising funds. The company will evaluate various fundraising methods, including the issuance of warrants, convertible securities, a Preferential Issue, or a Rights Issue. The final decision is subject to regulatory, statutory, and shareholder approvals. Additionally, the trading window for company shares remains closed until 48 hours after the announcement of the unaudited financial results for the quarter ended 30th Jun'26.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ashwani Khemka
Acquisition/ Disposal of Shares · 25 Jun 2026, 8:44 pm
Promoter Ashwani Khemka Increases Stake in Sanjivani Paranteral Promoter Ashwani Khemka acquired 16,875 shares (0.14% of total capital) of Sanjivani Paranteral Limited via an open market transaction on 24th Jun'26. Following the acquisition, Khemka's total holding increased from 36,53,242 shares (29.74%) to 36,70,117 shares, representing 29.88% of the company's total and diluted share capital. The total voting capital of the company stands at Rs. 12,28,43,000, comprising 1,22,84,300 shares at Rs. 10 each. This transaction further consolidates the promoter group's holding.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ashwani Khemka
Acquisition/ Disposal of Shares · 11 Jun 2026, 8:39 pm
Promoter Ashwani Khemka Increases Stake in Sanjivani Paranteral Ashwani Khemka, a promoter of Sanjivani Paranteral Ltd, acquired 17,500 shares, representing 0.14% of the company's capital, through an open market transaction on 10 Jun'26. This purchase increased Khemka's total holding from 36,35,742 shares (29.60%) to 36,53,242 shares (29.74%). The transaction was disclosed under SEBI's Substantial Acquisition of Shares and Takeovers Regulations, 2011. This move signals a consolidation of the promoter's stake in the company.
Dear Sir/Madam, Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations'), ....
Outcome · 21 May 2026, 6:55 pm
Sanjivani Paranteral Approves Valuer for Preferential Warrant Issue Sanjivani Paranteral's Board, at its meeting on 21st May'26, approved the appointment of Mr. Bhavesh M. Rathod, a Registered Valuer. The valuer will determine the issue price for a proposed preferential issuance of warrants. This action is a key step in the company's plan to raise funds, subject to necessary approvals from members and regulatory authorities. The preferential issue is being conducted under the provisions of the Companies Act, 2013 and SEBI ICDR Regulations.
Earnings call Transcript as on dated 15th May, 2026
Transcript · 20 May 2026, 10:12 pm
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of the earnings call with analysts and investors held on 15th ....
Audio / Video · 16 May 2026, 4:34 pm
Sanjivani Paranteral Publishes Q4 & FY26 Earnings Call Recording Sanjivani Paranteral Limited has published the audio recording of its earnings call held on 15 May'26. The call discussed the audited financial results for the fourth quarter and full year ended 31 Mar'26. This disclosure complies with SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015. The recording is accessible via a link provided in the company's filing to the BSE on 16 May'26. This follows the release of the company's financial performance data for the period.
As per attached Document
Press Release · 15 May 2026, 9:44 pm
Sanjivani Paranteral Reports FY26 Results with PAT at ₹66.94 mn Sanjivani Paranteral reported consolidated FY26 results with total income of ₹697.56 mn. EBITDA stood at ₹114.00 mn with a margin of 16.34%, while PAT reached ₹66.94 mn, yielding a 9.60% margin and an EPS of ₹5.49. For Q4 FY26, total income was ₹138.09 mn with a PAT of ₹5.48 mn. The company commenced commercial production at its new IV Fluid Infusion plant in Pune. In FY26, Injectables and Tablets contributed 53.45% and 43.10% to revenue, respectively, with exports comprising 78.50% of revenue from operations.
Sanjivani Paranteral Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2026 ,inter alia, to consider and approve the proposal for raising ....
Intimation · 15 May 2026, 8:50 pm
Sanjivani Paranteral Board to Consider Fundraising on 21st May'26 Sanjivani Paranteral (BSE: 531569) has scheduled a Board of Directors meeting for 21st May'26 to consider and approve a fundraising proposal. The company will evaluate various methods, including the issuance of equity shares or warrants. Potential routes for the capital raise include preferential issue, private placements, or qualified institutional placements (QIPs), among other suitable options. The final proposal will be subject to necessary regulatory and shareholder approvals. This move signals a potential upcoming capital infusion for the company.
Refer attached document
Investor Presentation · 15 May 2026, 12:21 am
Sanjivani Paranteral Reports Sharp Q4 FY26 Decline in Revenue and Profitability Sanjivani Paranteral posted weak Q4 FY26 standalone results, with revenue from operations falling 42.2% YoY to INR 105.1 mn. EBITDA declined 45.6% to INR 16.6 mn, and PAT dropped 57.3% to INR 9.4 mn. For the full year FY26, revenue was down 7.6% YoY to INR 647.6 mn, while PAT fell 14.5% to INR 69.2 mn. The significant quarterly downturn was driven by sharp YoY declines across injectables and orals, with exports constituting 85.3% of Q4 revenue. PAT margin for Q4 contracted by 346 bps to 8.3%.
Refer attached document
Financial Result · 14 May 2026, 11:24 pm
SANJIVANI PARANTERAL LIMITED - Financial Result for the Quarter ended 31st Mar'26 (Consolidated, INR Lacs) ■ Revenue: 1321 (-27.3% YoY | -40.1% QoQ) ■ EBITDA: 158 (-39.6% YoY | -58.9% QoQ) ■ EBITDA Margin (%): 11.9 (-243 bps YoY | -546 bps QoQ) ■ PAT: 70.4 (-67.8% YoY | -74.0% QoQ) ■ EPS (INR): 0.49 (-69.6% YoY | -77.8% QoQ)
Refer attached document
Outcome · 14 May 2026, 11:15 pm
SANJIVANI PARANTERAL LIMITED - Financial Result for the Quarter ended 31st Mar'26 (Consolidated, INR Lacs) ■ Revenue: 1321 (-27.3% YoY | -40.1% QoQ) ■ EBITDA: 158 (-39.6% YoY | -58.9% QoQ) ■ EBITDA Margin (%): 11.9 (-243 bps YoY | -546 bps QoQ) ■ PAT: 70.4 (-67.8% YoY | -74.0% QoQ) ■ EPS (INR): 0.49 (-69.6% YoY | -77.8% QoQ)